Related Experiment Videos
Melatonin in patients with reduced REM sleep duration: two randomized controlled trials
Dieter Kunz1, Richard Mahlberg, Cordula Müller
1Department of Psychiatry and Psychotherapy, Charité Campus Mitte-Universitätsmedizin Berlin, 10117 Berlin, Germany. dieter.kunz@charite.de
The Journal of Clinical Endocrinology and Metabolism
|January 13, 2004
Summary
Exogenous melatonin supplementation effectively normalized disturbed rapid-eye-movement (REM) sleep in patients with neuropsychiatric disorders. Melatonin increased REM sleep duration and continuity, improving daytime function without altering circadian phase.
Area of Science:
- Neuroscience
- Chronobiology
- Sleep Medicine
Background:
- Circadian rhythms regulate human physiology, including sleep-wake cycles.
- Rapid-eye-movement (REM) sleep is crucial for brain function, metabolism, and immunity.
- Disturbed REM sleep is common in neuropsychiatric disorders.
Purpose of the Study:
- To evaluate the efficacy of exogenous melatonin in patients with disturbed REM sleep.
- To assess melatonin's impact on REM sleep duration, continuity, and subjective daytime dysfunction.
Main Methods:
- Two randomized, double-blind, placebo-controlled trials involving 14 outpatients with neuropsychiatric sleep disorders.
- Patients received 3 mg of melatonin or placebo daily for 4 weeks.
- Diagnostic polysomnography and subjective measures were used for assessment.
Main Results:
- Melatonin significantly increased REM sleep percentage compared to placebo (17.8% vs. 12.0%).
- Melatonin improved subjective daytime dysfunction and clinical global impression scores.
- Melatonin enhanced REM sleep continuity and promoted nocturnal temperature decline, without shifting circadian phase.
Conclusions:
- Exogenous melatonin, timed appropriately, can normalize circadian variations in human physiology.
- Melatonin shows potential for improving sleep quality and overall health, particularly in vulnerable populations like the elderly and shift workers.